Drug Shortage Report for HYDROMORPH CONTIN
Report ID | 137503 |
Drug Identification Number | 02359510 |
Brand name | HYDROMORPH CONTIN |
Common or Proper name | HYDROmorphone* hydrochloride Controlled Release Capsules |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 9MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-04-15 |
Actual start date | 2021-04-15 |
Estimated end date | 2021-04-30 |
Actual end date | 2021-04-26 |
Shortage status | Resolved |
Updated date | 2021-04-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-04-15 | English | Compare |
v2 | 2021-04-15 | French | Compare |
v3 | 2021-04-16 | English | Compare |
v4 | 2021-04-23 | English | Compare |
v5 | 2021-04-23 | French | Compare |
v6 | 2021-04-26 | English | Compare |
v7 | 2021-04-26 | French | Compare |
v8 | 2021-04-27 | English | Compare |
Showing 1 to 8 of 8